The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
AM23-MN-26-O: ASHI/AABB Joint Session: The Problem with Platelets: How Perspectives of Various Practitioners Involved in Platelet Support of Refractory Patients Has Led to Continuing Controversies (Enduring)
Credits
1.5 General Continuing Education (GEN) | 1.5 Florida Lab Personnel (FLP) | 1.5 California Nurse (CN) | 1.5 California Lab Personnel (CLP) | 1.5 Physician (PHY)
$30$30.00
Standard Price
Members save $5
In this session, we will demonstrate how various practitioners caring for the same immune refractory patient can have widely different practices regarding platelet support for the patient. We will show how this can lead to delays in treatment, less than effective treatment for the patient, and a waste of a scarce resource. We will propose current best practices and better communication among the practitioners involved. Additionally, we will introduce Platelet Refractory Evaluation Workgroup, which has been formed to outline the perceptions, expectations, limitations, and efficacy of managing platelet refractory patients.
Learning Objectives
Explain the perspectives of the hematologist ordering platelets, the transfusion service issuing the platelet product, HLA laboratory performing HLA antibody testing and the blood collection center providing platelets
List the tests available that provide appropriate information leading to selection of the best platelet products for transfusion
Describe the testing used to monitor platelet effectiveness
Describe algorithms that utilize HLA testing to select the optimal platelet products for platelet immune refractory patients
All relevant financial relationships have been mitigated.
By completing the evaluation, you are attesting to watching the presentation in its entirety. A certificate will be immediately provided after submission.
Credits Available
Purchasing this session will automatically provide ownership of all the individually purchasable attached CE products, regardless of their stated individual purchase restrictions.
AM23-MN-26-O: ASHI/AABB Joint Session: The Problem with Platelets: How Perspectives of Various Practitioners Involved in Platelet Support of Refractory Patients Has Led to Continuing Controversies (Enduring) Evaluation
Join us for an essential panel discussion on cybersecurity in healthcare, where real-world insights and expert analysis come together to enhance your organization's defenses. This session features three distinguished speakers from hospitals and blood centers that have faced cybersecurity attacks…